Cardiovascular Benefits: GLP-1s have shown cardiovascular protective effects, reducing risk of heart attack and stroke in people with type 2 diabetes 4
The mechanism is well established and has decades of consistent clinical evidence behind it
Clinical Pharmacology and Therapeutics
22, n o 6, 343352 (ISSN 0263-6484, PMID 15386533, DOI 10.1002/cbf.1149, lire en ligne, consult le Nutrition Reviews 54: 130, 1996 Clinical Science 91: 575582, 1996 American Journal of Medical Science 307: 119127, 1994 Gut 42: 492, 1998 American Journal of Gastroenterology 91: 25692573, 1996 Nephron 61: 404408, 1992 Early Human Development 37: 167174, 1994 (en) Hinson JA, Andrews LS, Gillette JR., Kinetic evidence for multiple chemically reactive intermediates in the breakdown of phenacetin N-O-glucuronide
Most users find themselves less hungry and more satiated